MAP2K7 and nonpapillary renal cell carcinoma: ZIC2 can activate TGF-β, Src/FAK, Notch, Raf/MEK/ERK, and Wnt/β-catenin signaling pathway in colorectal cancer, non-small cell lung cancer, endometrial cancer, liver cancer, and ccRCC cells 28, 35-39.